David C. Olson, PhD — President and Chief Executive Officer
David is a serial entrepreneur who has co-founded 6 biotech start-ups, managed other early-stage businesses, and authored business plans backed by more than $50M private and $2M public funding. He specializes in commercializing life science technologies and has more than 15 years experience in company building, life science research and product development, intellectual property management, business development and venture financing. Most recently he was a founding member and senior executive of Accuri Cytometers (acquired by Becton Dickinson in 2011), which developed a successful product line of flow cytometers (life science research tools). David was responsible for creating Accuri’s product vision and played a central role in all aspects of corporate strategy, including financing and business development.
David received his doctorate in Molecular Biology from Princeton University, completed a postdoctoral fellowship at the University of California, San Francisco, and is currently Adjunct Faculty at the University of Michigan Medical School.
Vladimir Makarov, PhD — Chief Scientific Officer
Vladimir has a track record of developing novel research and diagnostic methods and tools. His experience spans more than 30 years in cutting edge molecular biology and life science research, with broad expertise in different fields of science including physics, molecular biology, genomics, and molecular diagnostics. Vladimir has authored more than 30 issued and pending patents and 60 scientific publications. He has co-founded 2 biotech start-ups, leading to development and commercialization of more than 10 different products in the research tools and diagnostics space. Prior to Swift, Vladimir served as Chief Scientific Officer of Rubicon Genomics, and was the key inventor of Rubicon products. Vladimir was responsible for creating Rubicon’s product vision, research and development, and intellectual property management.
Vladimir received his PhD in Physics and Mathematics from St. Petersburg University and has held senior scientist positions at the University of Michigan (Ann Arbor) and the Institute of Molecular Biology (Moscow).
Eric Halverson — Vice President of Finance
Eric joined Swift in April 2013, after serving as a consultant to the company since the fall of 2011. Eric has over 15 years of early stage operations experience, including over 10 years in the life science industry. Prior to joining Swift, Eric was Director of Finance at Atterocor where he was responsible for establishing the financial operations of the company from inception through seed and Series A ($16M) fund raising. Prior to Atterocor, Eric was the Managing Director of Diag Ventures, a consultancy, focused of the financial and operational development of early stage companies. Eric began his finance and accounting career with Arthur Andersen LLP.
Eric possess an MBA with a concentration in Finance and Corporate Strategy from the University of Michigan’s Ross School of Business, an BA from the University of Michigan, and is a licensed CPA in the state of California.